Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic miniMed Group, Inc. (Nasdaq: MMED) — Standalone Net Sales ($M) ($M)
MiniMed Group, Inc. (CIK 0002062583) Form 10-K/10-Q/8-K/424B4 & FY26Q4 / Sept 2026 Presentations
Latest, FY2026
3,102
Period ended Apr 30, 2026
Change on a year earlier
+14.3%
2,715 in FY2025
History
4 years
Since FY2023
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MiniMed Group, Inc. (Nasdaq: MMED) — Standalone Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 3,102 | +14.3% | MiniMed Group Investor Presentation (September 2026) ↗ |
| FY2025 | Apr 30, 2025 | 2,715 | +10.0% | MiniMed Group Investor Presentation (September 2026) ↗ |
| FY2024 | Apr 30, 2024 | 2,469 | +10.0% | MiniMed Group (MMED) 424B4 — ipo_424b4 (filed 2026-03-06) ↗ |
| FY2023 | Apr 30, 2023 | 2,245 | – | MiniMed Group (MMED) 424B4 — ipo_424b4 (filed 2026-03-06) ↗ |
Breakdown
What makes up minimed group, inc. (nasdaq: mmed) — standalone net sales ($m)
- MiniMed — Organic Revenue Growth YoY (%)8.0% · FY2026
- MiniMed — U.S. Net Sales ($M)917 · FY2026
- MiniMed — International Net Sales ($M)2,185 · FY2026
- MiniMed — Adjusted Standalone EBITDA ($M)482 · FY2026
- MiniMed — Adjusted EBITDA ($M)202 · FY2026
- MiniMed — Adjusted Gross Profit ($M)1,787 · FY2026
- MiniMed — Adjusted Standalone Operating Income ($M)0 · FY2026
- MiniMed — Adjusted Standalone Net Income ($M)0 · FY2026
- MiniMed — GAAP Gross Profit ($M)1,680 · FY2026
- MiniMed — GAAP R&D Expense ($M)448 · FY2026
- MiniMed — GAAP SG&A Expense ($M)1,183 · FY2026
- MiniMed — GAAP Operating Income / (Loss) ($M)-189 · FY2026
- MiniMed — GAAP Net Income / (Loss) ($M)-316 · FY2026
- MiniMed — Standalone Inventories ($M)341 · FY2026
- MiniMed — Standalone Remaining Performance Obligations ($M)39 · FY2026
- MiniMed — Standalone Contract Liabilities ($M)19 · FY2026
- MiniMed — Customer Refund & Return Liabilities ($M)45 · FY2026
- MiniMed — Property, Plant & Equipment, Net ($M)711 · FY2026
- MiniMed — Goodwill ($M)2,300 · FY2026
Cite this data
StockData. (2026). Medtronic MiniMed Group, Inc. (Nasdaq: MMED) — Standalone Net Sales ($M) ($M), annual FY2023–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/mmed-sub-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.